This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1989:3 Suppl 1:S111-8.

doi: 10.1097/00002030-198901001-00016.

HIV antibodies and vaccine design

D P Bolognesi¹

Affiliations

PMID: 2482052
DOI: 10.1097/00002030-198901001-00016

Review

HIV antibodies and vaccine design

D P Bolognesi. AIDS. 1989.

. 1989:3 Suppl 1:S111-8.

doi: 10.1097/00002030-198901001-00016.

Author

D P Bolognesi¹

Affiliation

¹ Department of Surgery, Duke University Medical Center, Durham, NC 27710.

PMID: 2482052
DOI: 10.1097/00002030-198901001-00016

No abstract available

PubMed Disclaimer

Similar articles

AIDS 1989. Vaccines and immunology: overview.
Laurence J, Schild GC. Laurence J, et al. AIDS. 1989;3 Suppl 1:S97-100. doi: 10.1097/00002030-198901001-00014. AIDS. 1989. PMID: 2514762 Review. No abstract available.
Immortalization of antigen selected B cells.
Steenbakkers PG, van Wezenbeek PM, Olijve W. Steenbakkers PG, et al. J Immunol Methods. 1993 Jul 6;163(1):33-40. doi: 10.1016/0022-1759(93)90236-z. J Immunol Methods. 1993. PMID: 7687638
Humoral immunity to the human immunodeficiency virus.
Weber J. Weber J. Curr Opin Immunol. 1989-1990 Feb;2(3):420-3. doi: 10.1016/0952-7915(89)90153-2. Curr Opin Immunol. 1989. PMID: 2483884 Review. No abstract available.
How does the HIV escape cytotoxic T cell immunity?
Phillips RE, McMichael AJ. Phillips RE, et al. Chem Immunol. 1993;56:150-64. Chem Immunol. 1993. PMID: 7680867 Review. No abstract available.
[AIDS vaccines: an enigma in vaccine development].
Dorner F, Barrett N. Dorner F, et al. Wien Klin Wochenschr. 1990 Jan 19;102(2):51-8. Wien Klin Wochenschr. 1990. PMID: 1689919 Review. German.

See all similar articles

Cited by

Expression and characterization of genetically engineered human immunodeficiency virus-like particles containing modified envelope glycoproteins: implications for development of a cross-protective AIDS vaccine.
Rovinski B, Haynes JR, Cao SX, James O, Sia C, Zolla-Pazner S, Matthews TJ, Klein MH. Rovinski B, et al. J Virol. 1992 Jul;66(7):4003-12. doi: 10.1128/JVI.66.7.4003-4012.1992. J Virol. 1992. PMID: 1602531 Free PMC article.
Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients.
Durali D, Morvan J, Letourneur F, Schmitt D, Guegan N, Dalod M, Saragosti S, Sicard D, Levy JP, Gomard E. Durali D, et al. J Virol. 1998 May;72(5):3547-53. doi: 10.1128/JVI.72.5.3547-3553.1998. J Virol. 1998. PMID: 9557634 Free PMC article.
Increase in soluble CD4 binding to and CD4-induced dissociation of gp120 from virions correlates with infectivity of human immunodeficiency virus type 1.
Willey RL, Martin MA, Peden KW. Willey RL, et al. J Virol. 1994 Feb;68(2):1029-39. doi: 10.1128/JVI.68.2.1029-1039.1994. J Virol. 1994. PMID: 7904656 Free PMC article.
Continuous epitopes of the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein and reactivity of human sera to synthetic peptides representing various HIV-1 isolates.
Horal P, Svennerholm B, Jeansson S, Rymo L, Hall WW, Vahlne A. Horal P, et al. J Virol. 1991 May;65(5):2718-23. doi: 10.1128/JVI.65.5.2718-2723.1991. J Virol. 1991. PMID: 1707985 Free PMC article.
Vertical transmission of human immunodeficiency virus (HIV) infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1.
Ugen KE, Goedert JJ, Boyer J, Refaeli Y, Frank I, Williams WV, Willoughby A, Landesman S, Mendez H, Rubinstein A, et al. Ugen KE, et al. J Clin Invest. 1992 Jun;89(6):1923-30. doi: 10.1172/JCI115798. J Clin Invest. 1992. PMID: 1601999 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database